Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
10/2010
10/26/2010US7820425 Method of cryopreserving selected sperm cells
10/26/2010US7820424 Modified hydrolase for use as template for inverse polymerase chain reaction
10/26/2010US7820413 Incrementally truncated nucleic acids and methods of making same
10/26/2010US7820409 Chimeric human growth hormone derived from the placenta and pituitary isoform and processes for obtaining said chimera
10/26/2010US7820400 Tumor-associated marker
10/26/2010US7820384 Methods and compositions for protein expression and purification
10/26/2010US7820379 Process for high throughput screening of CpG-based immuno-agonist/antagonist
10/26/2010US7820191 Hardened matrix for propagation of tissue to be used in repairing hard tissue defects; tissue engineering and regenerative medicine
10/26/2010US7820178 VEGF isoforms and their use as anti-angiogenic, anti-vasodilatory, anti-permeability and anti-proliferative agents
10/26/2010US7820169 inhibiting the activity of tumor necrosis factor TNF in a patient having rheumatoid arthritis or psoriatic arthritis, by administering a composition comprising an effective amount of human anti-TNF antibody comprising a heavy chain variable region comprising SEQ ID NO:7 and a light chain variable
10/26/2010US7820162 Methods for chemically synthesizing immunoglobulin chimeric proteins
10/26/2010US7820158 Ligand-coupled initiator polymers and methods of use
10/26/2010US7820157 Retroviral vector comprising nucleotide sequences coding collagen domain for use in wound healing; tissue repair and engineering; regenerative medicine
10/26/2010US7819796 Embryo modification and implantation
10/26/2010CA2579391C Anti-a33 antibody
10/26/2010CA2443840C Cripto blocking antibodies and uses thereof
10/26/2010CA2426398C Methods of modifying eukaryotic cells
10/26/2010CA2416602C Nucleotide sequences of a new class of diverged delta-9 stearoyl-acp desaturase genes
10/26/2010CA2409698C Neural progenitor cell populations
10/26/2010CA2393343C Nadh oxidase from lactobacillus
10/26/2010CA2381229C Stabilized g-csf preparations
10/26/2010CA2351887C Psca: prostate stem cell antigen and uses thereof
10/26/2010CA2326501C Binding molecules derived from immunoglobulins which do not trigger complement mediated lysis
10/26/2010CA2319211C Recombinant proteins derived from hgf and msp
10/26/2010CA2291138C Transplants for myocardial scars and method and cellular preparations therefor
10/21/2010WO2010121213A2 Antibacterial compositions
10/21/2010WO2010121159A1 Method for the induction of a reward response by modulation of dopaminergic systems in the central nervous system
10/21/2010WO2010121122A2 Biomechanical induction of hematopoiesis
10/21/2010WO2010121008A2 Methods for enhancing hematopoietic progenitor cell engraftment
10/21/2010WO2010120785A2 Methods and compositions for stem cell cultures
10/21/2010WO2010120749A2 Harnessing cell dynamics to engineer materials
10/21/2010WO2010120561A1 Anti-fcrh5 antibodies and immunoconjugates and methods of use
10/21/2010WO2010120557A1 Improved endoglucanases
10/21/2010WO2010120329A1 Reconstituted tumor microenvironment for anticancer drug development
10/21/2010WO2010120002A1 Black-lip pearl oyster egg extract, and method for assessing the productive effort of a black-lip pearl oyster using a black-lip pearl oyster egg extract-specific polyclonal antibody
10/21/2010WO2010119828A1 Method for culturing bone marrow stromal cells and mesenchymal stem cells, and method for producing graft cells for treating central neurological disease
10/21/2010WO2010119819A1 Method of preparing human lung tissue stem cells and method of inducing differentiation into human alveolar epithelial cells
10/21/2010WO2010119721A1 Stable artificial bioluminescent enzyme having super-high brightness
10/21/2010WO2010119693A1 Method of screening for insulin secretion-potentiating agents
10/21/2010WO2010119403A2 Cellular electric stimulation mediated by piezoelectric nanotubes
10/21/2010WO2010119176A1 Cell culture supplement
10/21/2010WO2010119039A1 Engineered mesenchymal stem cells and method of using same to treat tumors
10/21/2010WO2010119001A1 Prostate cancer cell lines and their use in screening method
10/21/2010WO2010118873A1 Vector for transporting microbiological organisms to foci of a disease
10/21/2010WO2010118632A1 Bt protein cry4cb2, encoding gene of same and use thereof
10/21/2010WO2010099414A3 Protection of human corneal endothelial against cell death under storage conditions by anti-apoptotic genes
10/21/2010WO2010062951A3 Animal model for osteoarthritis and intervertebral disc disease
10/21/2010US20100269229 Isolated Polynucleotide Molecules Corresponding to Mutant and Wild-Type Alleles of the Maize D9 Gene and Methods of Use
10/21/2010US20100269227 Tissue specific promoters
10/21/2010US20100269226 Tissue specific promoters
10/21/2010US20100269225 Tissue specific promoters
10/21/2010US20100269224 Multiple Virus Resistance in Plants
10/21/2010US20100269222 Root active promoters, and uses thereof
10/21/2010US20100269221 Novel Bacillus Thuringiensis Gene with Lepidopteran Activity
10/21/2010US20100269219 Plants having enhanced yield-related traits and a method for making the same
10/21/2010US20100269217 Compositions and Methods for Altering the Morphology of Plants
10/21/2010US20100269215 Tfla gene which can degrade toxoflavin and its chemical derivatives and transgenic organisms expressing tfla gene
10/21/2010US20100269213 Rice Nucleic Acid Molecules and Other Molecules Associated with Plants and Uses Thereof for Plant Improvement
10/21/2010US20100269200 Plants and seeds of hybrid corn variety ch997005
10/21/2010US20100269194 Soybean variety xb07s09
10/21/2010US20100269193 Soybean variety xb007e09
10/21/2010US20100269189 Soybean variety xb20w09
10/21/2010US20100269188 Soybean variety xb31ag09
10/21/2010US20100269185 Soybean variety xb15q09
10/21/2010US20100269184 Apo-2DcR
10/21/2010US20100269183 Micro-rnas that control myosin expression and myofiber identity
10/21/2010US20100269161 Method and system for preventing fraudulent activities
10/21/2010US20100267930 SLO2 and SLO4, Novel Potassium Channel Proteins from Human Brain
10/21/2010US20100267816 Human anti-amyloid beta peptide antibody and fragment of said antibody
10/21/2010US20100267815 PFKFB4 Inhibitors And Methods Of Using The Same
10/21/2010US20100267810 Methods and compositions for treating neurological disease
10/21/2010US20100267806 LIPID FORMULATED COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF Eg5 AND VEGF GENES
10/21/2010US20100267804 Differential expression of micrornas in nonfailing versus failing human hearts
10/21/2010US20100267802 Delivery method
10/21/2010US20100267781 Naphthalene-based inhibitors of anti-apoptotic proteins
10/21/2010US20100267768 Process for making modulators of cystic fibrosis transmembrane conductance regulator
10/21/2010US20100267725 Compounds, Compositions and Methods Comprising 4N-Substituted Triazole Derivatives
10/21/2010US20100267711 Method of enhancing cellular production of molecular chaperone, hydroxylamine derivatives useful for enhancing the chaperone production and the preparation thereof
10/21/2010US20100267704 Autophagy Inducing Compounds and Uses Thereof in Treating Autophagy Associated Diseases
10/21/2010US20100267698 Benzimidazole and Pyridylimidazole Derivatives
10/21/2010US20100267696 Amido-Thiophene Compounds and Their Use as 11-Beta-HSD1 Inhibitors
10/21/2010US20100267684 Use of biological surfactant as anti-inflammatory agent and tissue preservative solution
10/21/2010US20100267661 Beta glucans and methods of use thereof
10/21/2010US20100267651 T cell antigen receptor peptides
10/21/2010US20100267647 Modulating photoreactivity in a cell
10/21/2010US20100267646 Trophic Factor for the Treatment of Retinal Degenerative Diseases
10/21/2010US20100267641 Prognostic tests for development of dermal stretch marks and implications for the preventative treatment thereof
10/21/2010US20100267627 Support for protein transfer, protein transfer agent using the support, protein transfer method, cell having protein transferred thereinto and method of producing the same
10/21/2010US20100267623 Peptides with capacity to bind to scurfin and applications
10/21/2010US20100267622 Methods to activate or block the HLA-E/Qa-1 restricted CD8+ T cell regulatory pathway to treat immunological disease
10/21/2010US20100267571 Novel method for specimen preparation, which ensures preservation of tissue morphology and nucleic acid quality
10/21/2010US20100267145 Immunocompetent cell having anti-cd38 antibody on its cell surface
10/21/2010US20100267144 Systems and methods for controlled pervaporation in horticultural cellular tissue
10/21/2010US20100267143 Method for Surface Modification of Polymeric Scaffold for Stem Cell Transplantation Using Decellularized Extracellular Matrix
10/21/2010US20100267142 Scalable packed-bed cell culture device
10/21/2010US20100267141 Chemical approaches for generation of induced pluripotent stem cells
10/21/2010US20100267140 Soluble inhibitors of vascular endothelial growth factor and use thereof
10/21/2010US20100267139 Osteopontin nanoparticle system for drug delivery
10/21/2010US20100267138 Compositions and methods comprising a ligand of chemerinr
10/21/2010US20100267137 Methods for inducing the differentiation of blood monocytes into functional dendritic cells
1 ... 442 443 444 445 446 447 448 449 450 451 452 453 454 455 456 457 458 459 460 461 462 ... 1827